Cargando…

NOP2/Sun RNA methyltransferase 2 promotes tumor progression via its interacting partner RPL6 in gallbladder carcinoma

NOP2/Sun domain family, member 2 (NSUN2) is a nuclear RNA methyl‐transferase catalyzing 5‐methylcytosine formation. Evidence shows that NSUN2 is correlated with cell unlimited proliferation. However, its functional role in gallbladder carcinoma (GBC), which is the most common biliary tract malignanc...

Descripción completa

Detalles Bibliográficos
Autores principales: Gao, Yuan, Wang, Zheng, Zhu, Yidi, Zhu, Qin, Yang, Yang, Jin, Yunpeng, Zhang, Fei, Jiang, Lin, Ye, Yuanyuan, Li, Huaifeng, Zhang, Yichi, Liang, Haibin, Xiang, Shanshan, Miao, Huijie, Liu, Yingbin, Hao, Yajuan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6825013/
https://www.ncbi.nlm.nih.gov/pubmed/31487418
http://dx.doi.org/10.1111/cas.14190
_version_ 1783464827183693824
author Gao, Yuan
Wang, Zheng
Zhu, Yidi
Zhu, Qin
Yang, Yang
Jin, Yunpeng
Zhang, Fei
Jiang, Lin
Ye, Yuanyuan
Li, Huaifeng
Zhang, Yichi
Liang, Haibin
Xiang, Shanshan
Miao, Huijie
Liu, Yingbin
Hao, Yajuan
author_facet Gao, Yuan
Wang, Zheng
Zhu, Yidi
Zhu, Qin
Yang, Yang
Jin, Yunpeng
Zhang, Fei
Jiang, Lin
Ye, Yuanyuan
Li, Huaifeng
Zhang, Yichi
Liang, Haibin
Xiang, Shanshan
Miao, Huijie
Liu, Yingbin
Hao, Yajuan
author_sort Gao, Yuan
collection PubMed
description NOP2/Sun domain family, member 2 (NSUN2) is a nuclear RNA methyl‐transferase catalyzing 5‐methylcytosine formation. Evidence shows that NSUN2 is correlated with cell unlimited proliferation. However, its functional role in gallbladder carcinoma (GBC), which is the most common biliary tract malignancy and has a poor prognosis, remains to be determined. Here we found that NSUN2 was highly expressed in GBC tissues as well as cell lines. NSUN2 silencing repressed GBC cell proliferation and tumorigenesis both in vitro and in vivo. Conversely, upregulation of NSUN2 enhanced GBC cell growth and colony formation. We further discovered that RPL6 was a closely interacting partner with NSUN2. Silencing RPL6 resulted in insufficient NSUN2 translational level and accumulative NSUN2 transcriptional level. Exogenous expression of NSUN2 partially rescued the effect of RPL6 in gallbladder cancer progression. Taken together, our data provided novel mechanic insights into the function of NSUN2 in GBC, thus pointing to NSUN2 as a potential and effective therapeutic approach to GBC treatment.
format Online
Article
Text
id pubmed-6825013
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-68250132019-11-07 NOP2/Sun RNA methyltransferase 2 promotes tumor progression via its interacting partner RPL6 in gallbladder carcinoma Gao, Yuan Wang, Zheng Zhu, Yidi Zhu, Qin Yang, Yang Jin, Yunpeng Zhang, Fei Jiang, Lin Ye, Yuanyuan Li, Huaifeng Zhang, Yichi Liang, Haibin Xiang, Shanshan Miao, Huijie Liu, Yingbin Hao, Yajuan Cancer Sci Original Articles NOP2/Sun domain family, member 2 (NSUN2) is a nuclear RNA methyl‐transferase catalyzing 5‐methylcytosine formation. Evidence shows that NSUN2 is correlated with cell unlimited proliferation. However, its functional role in gallbladder carcinoma (GBC), which is the most common biliary tract malignancy and has a poor prognosis, remains to be determined. Here we found that NSUN2 was highly expressed in GBC tissues as well as cell lines. NSUN2 silencing repressed GBC cell proliferation and tumorigenesis both in vitro and in vivo. Conversely, upregulation of NSUN2 enhanced GBC cell growth and colony formation. We further discovered that RPL6 was a closely interacting partner with NSUN2. Silencing RPL6 resulted in insufficient NSUN2 translational level and accumulative NSUN2 transcriptional level. Exogenous expression of NSUN2 partially rescued the effect of RPL6 in gallbladder cancer progression. Taken together, our data provided novel mechanic insights into the function of NSUN2 in GBC, thus pointing to NSUN2 as a potential and effective therapeutic approach to GBC treatment. John Wiley and Sons Inc. 2019-09-23 2019-11 /pmc/articles/PMC6825013/ /pubmed/31487418 http://dx.doi.org/10.1111/cas.14190 Text en © 2019 The Authors. Cancer Science published by John Wiley & Sons Australia, Ltd on behalf of Japanese Cancer Association. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Original Articles
Gao, Yuan
Wang, Zheng
Zhu, Yidi
Zhu, Qin
Yang, Yang
Jin, Yunpeng
Zhang, Fei
Jiang, Lin
Ye, Yuanyuan
Li, Huaifeng
Zhang, Yichi
Liang, Haibin
Xiang, Shanshan
Miao, Huijie
Liu, Yingbin
Hao, Yajuan
NOP2/Sun RNA methyltransferase 2 promotes tumor progression via its interacting partner RPL6 in gallbladder carcinoma
title NOP2/Sun RNA methyltransferase 2 promotes tumor progression via its interacting partner RPL6 in gallbladder carcinoma
title_full NOP2/Sun RNA methyltransferase 2 promotes tumor progression via its interacting partner RPL6 in gallbladder carcinoma
title_fullStr NOP2/Sun RNA methyltransferase 2 promotes tumor progression via its interacting partner RPL6 in gallbladder carcinoma
title_full_unstemmed NOP2/Sun RNA methyltransferase 2 promotes tumor progression via its interacting partner RPL6 in gallbladder carcinoma
title_short NOP2/Sun RNA methyltransferase 2 promotes tumor progression via its interacting partner RPL6 in gallbladder carcinoma
title_sort nop2/sun rna methyltransferase 2 promotes tumor progression via its interacting partner rpl6 in gallbladder carcinoma
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6825013/
https://www.ncbi.nlm.nih.gov/pubmed/31487418
http://dx.doi.org/10.1111/cas.14190
work_keys_str_mv AT gaoyuan nop2sunrnamethyltransferase2promotestumorprogressionviaitsinteractingpartnerrpl6ingallbladdercarcinoma
AT wangzheng nop2sunrnamethyltransferase2promotestumorprogressionviaitsinteractingpartnerrpl6ingallbladdercarcinoma
AT zhuyidi nop2sunrnamethyltransferase2promotestumorprogressionviaitsinteractingpartnerrpl6ingallbladdercarcinoma
AT zhuqin nop2sunrnamethyltransferase2promotestumorprogressionviaitsinteractingpartnerrpl6ingallbladdercarcinoma
AT yangyang nop2sunrnamethyltransferase2promotestumorprogressionviaitsinteractingpartnerrpl6ingallbladdercarcinoma
AT jinyunpeng nop2sunrnamethyltransferase2promotestumorprogressionviaitsinteractingpartnerrpl6ingallbladdercarcinoma
AT zhangfei nop2sunrnamethyltransferase2promotestumorprogressionviaitsinteractingpartnerrpl6ingallbladdercarcinoma
AT jianglin nop2sunrnamethyltransferase2promotestumorprogressionviaitsinteractingpartnerrpl6ingallbladdercarcinoma
AT yeyuanyuan nop2sunrnamethyltransferase2promotestumorprogressionviaitsinteractingpartnerrpl6ingallbladdercarcinoma
AT lihuaifeng nop2sunrnamethyltransferase2promotestumorprogressionviaitsinteractingpartnerrpl6ingallbladdercarcinoma
AT zhangyichi nop2sunrnamethyltransferase2promotestumorprogressionviaitsinteractingpartnerrpl6ingallbladdercarcinoma
AT lianghaibin nop2sunrnamethyltransferase2promotestumorprogressionviaitsinteractingpartnerrpl6ingallbladdercarcinoma
AT xiangshanshan nop2sunrnamethyltransferase2promotestumorprogressionviaitsinteractingpartnerrpl6ingallbladdercarcinoma
AT miaohuijie nop2sunrnamethyltransferase2promotestumorprogressionviaitsinteractingpartnerrpl6ingallbladdercarcinoma
AT liuyingbin nop2sunrnamethyltransferase2promotestumorprogressionviaitsinteractingpartnerrpl6ingallbladdercarcinoma
AT haoyajuan nop2sunrnamethyltransferase2promotestumorprogressionviaitsinteractingpartnerrpl6ingallbladdercarcinoma